Ameritas Investment Partners’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $350K | Hold |
24,184
| – | – | 0.01% | 969 |
|
|
2025
Q4 | $344K | Buy |
24,184
+921
| +4% | +$9.05K | 0.01% | 959 |
|
|
2025
Q3 | $183K | Sell |
23,263
-5,166
| -18% | -$36.8K | 0.01% | 1291 |
|
|
2025
Q2 | $163K | Sell |
28,429
-2,267
| -7% | -$14.6K | 0.01% | 1428 |
|
|
2025
Q1 | $250K | Hold |
30,696
| – | – | 0.01% | 1137 |
|
|
2024
Q4 | $289K | Buy |
30,696
+1,280
| +4% | +$13.3K | 0.01% | 1108 |
|
|
2024
Q3 | $314K | Hold |
29,416
| – | – | 0.01% | 1060 |
|
|
2024
Q2 | $292K | Hold |
29,416
| – | – | 0.01% | 1031 |
|
|
2024
Q1 | $347K | Hold |
29,416
| – | – | 0.01% | 958 |
|
|
2023
Q4 | $417K | Buy |
29,416
+1,555
| +6% | +$17.7K | 0.02% | 868 |
|
|
2023
Q3 | $339K | Buy |
27,861
+4,704
| +20% | +$60.7K | 0.01% | 901 |
|
|
2023
Q2 | $291K | Buy |
23,157
+1,535
| +7% | +$18.2K | 0.01% | 937 |
|
|
2023
Q1 | $240K | Hold |
21,622
| – | – | 0.01% | 995 |
|
|
2022
Q4 | $282K | Hold |
21,622
| – | – | 0.01% | 954 |
|
|
2022
Q3 | $225K | Buy |
21,622
+1,003
| +5% | +$11.2K | 0.01% | 1004 |
|
|
2022
Q2 | $221K | Hold |
20,619
| – | – | 0.01% | 1016 |
|
|
2022
Q1 | $195K | Hold |
20,619
| – | – | 0.01% | 1201 |
|
|
2021
Q4 | $238K | Hold |
20,619
| – | – | 0.01% | 1123 |
|
|
2021
Q3 | $197K | Hold |
20,619
| – | – | 0.01% | 1209 |
|
|
2021
Q2 | $199K | Sell |
20,619
-1,048
| -5% | -$10.2K | 0.01% | 1254 |
|
|
2021
Q1 | $214K | Hold |
21,667
| – | – | 0.01% | 1164 |
|
|
2020
Q4 | $500K | Hold |
21,667
| – | – | 0.02% | 768 |
|
|
2020
Q3 | $306K | Sell |
21,667
-695
| -3% | -$10.1K | 0.01% | 861 |
|
|
2020
Q2 | $337K | Hold |
22,362
| – | – | 0.02% | 820 |
|
|
2020
Q1 | $207K | Hold |
22,362
| – | – | 0.01% | 918 |
|
|
2019
Q4 | $218K | Buy |
22,362
+1,083
| +5% | +$9.91K | 0.01% | 1041 |
|
|
2019
Q3 | $171K | Buy |
21,279
+1,476
| +7% | +$16K | 0.01% | 1143 |
|
|
2019
Q2 | $247K | Buy |
19,803
+4,146
| +26% | +$52.6K | 0.01% | 959 |
|
|
2019
Q1 | $213K | Hold |
15,657
| – | – | 0.01% | 1010 |
|
|
2018
Q4 | $150K | Hold |
15,657
| – | – | 0.01% | 1121 |
|
|
2018
Q3 | $189K | Hold |
15,657
| – | – | 0.01% | 1116 |
|
|
2018
Q2 | $245K | Hold |
15,657
| – | – | 0.01% | 965 |
|
|
2018
Q1 | $235K | Buy |
15,657
+1,600
| +11% | +$24.4K | 0.01% | 993 |
|
|
2017
Q4 | $202K | Buy |
14,057
+1,754
| +14% | +$24.1K | 0.01% | 1080 |
|
|
2017
Q3 | $171K | Hold |
12,303
| – | – | 0.01% | 1144 |
|
|
2017
Q2 | $124K | Hold |
12,303
| – | – | 0.01% | 1339 |
|
|
2017
Q1 | $88K | Hold |
12,303
| – | – | ﹤0.01% | 1499 |
|
|
2016
Q4 | $61K | Hold |
12,303
| – | – | ﹤0.01% | 1106 |
|
|
2016
Q3 | $91K | Buy |
+12,303
| New | +$83.1K | 0.01% | 1071 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Ameritas Investment Partners's FOLD Position: Q1 2026 in Review
Ameritas Investment Partners held its Amicus Therapeutics (FOLD) position steady in Q1 2026 at 24,184 shares worth $350K. The position accounts for 0.01% of the portfolio, ranked #969.
Ameritas Investment Partners first reported a position in FOLD in Q3 2016 and has held it in 39 quarters since. The position peaked at $500K in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Ameritas Investment Partners held 24,184 shares of Amicus Therapeutics worth $350K as of Q1 2026.
- Ameritas Investment Partners left its Amicus Therapeutics share count unchanged in Q1 2026.
- Amicus Therapeutics made up 0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #969 holding.
- Ameritas Investment Partners first reported a position in Amicus Therapeutics in Q3 2016 and has held it in 39 quarters since.
- Ameritas Investment Partners's Amicus Therapeutics position peaked at $500K in Q4 2020.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.